ABSTRACT. This study was primarily undertaken to test the hypothesis that mitochondrial DNA (mtDNA) mutations may be associated with aplastic anemia (AA). We analyzed mtDNA sequences from 15 patients with AA. The samples were obtained from bone marrow, and patients' oral epithelial cells were collected for normal tissue comparison. Total DNA was amplified by PCR after extraction, and these segments were then sent for sequencing. The results were compared with those of oral epithelial tissues as well as mtDNA sequences in the revised Cambridge Reference Sequence (rCRS) database. We detected 61 heteroplasmic mutations in 11 genes, including those encoding NADH dehydrogenase (ND)1-2 and 4-6, tRNA glutamic acid (TRNE), ribosomal RNA (RNR) 1 and 2, cytochrome c oxidase (COX1), cytochrome b (CYTB), and tRNA glycine (TRNG); mutation rates were particularly high in ND2
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INTRODUCTION
Aplastic anemia (AA) is a bone marrow failure syndrome characterized by peripheral pancytopenia and marrow hypoplasia. The damage to bone marrow may be triggered by environmental exposure, such as exposure to chemicals and drugs, or viral infections, and possibly, endogenous antigens generated by genetically altered bone marrow cells.
While most of a cell's genetic material is contained within the nucleus, mitochondria have their own circular DNA. They also have their own machinery for protein synthesis and reproduce by the process of fission, as in bacteria. Human mitochondrial DNA (mtDNA) is a 16-kb circle that contains genes encoding 13 electron transport chain proteins, 22 tRNAs, and 2 rRNAs (Shadel and Clayton, 1997; DiMauro and Schon, 2003) . Mitochondria are considered to be the "power houses of the cell" because they produce adenosine triphosphate (ATP) by systematically extracting energy from nutrient molecules (substrates) (Chinnery and Schon, 2003) . mtDNA is replicated with a high mutation rate because it has no protective histones and also lacks an effective DNA repair system. Moreover, mtDNA is located near the inner mitochondrial membrane, where it is far more exposed to oxygen-free radicals generated by the respiratory chain than is nuclear DNA (Richter et al., 1988; Penta et al., 2001) . Although the limited repair capacity hypothesis has been validated experimentally in some experimental systems, recent data have shown that base excision repair mechanisms do occur in mammalian mtDNA (Bohr et al., 2002; Chen et al., 2002) .
Several laboratories have reported unexpectedly large numbers of somatic mutations in leukemia and myelodysplastic syndromes (Grist et al., 2004; Linnartz et al., 2004; Wulfert et al., 2008) . Acquired deletions of mtDNA in the hematopoietic compartment have also been found to occur in association with severe pancytopenia and reticulocytopenia (Hatfill et al., 1993) . We hypothesized that AA may be associated with mtDNA aberrations. In the present study, we analyzed the entire mtDNA nucleotide sequences from 15 patients with AA and found that there were high mutational rates in the genes encoding NADH dehydrogenase (ND)1-2 and 4-6, cytochrome B (CYTB) and related genes [tRNA glutamic acid (TRNE), ri-ribosomal RNA (RNR) 1 and 2, cytochrome c oxidase (COX1), tRNA glycine (TRNG)], which are closely involved in oxidation in the respiratory chain. We were led to conclude that functional impairment of the mitochondrial respiration chain induced by gene mutation may be an important reason behind hematopoietic failure in AA. 
PATIENTS AND METHODS

Patients
Between September 2010 and February 2011, 15 patients, 7 males and 8 females (median age of 32.2 years; range 11-64), were included in this study. Eligible patients had histologically confirmed diagnosis of AA (Table 1 and Figure 1 ). These patients had no family history of hematologic disease, and most of them presented fatigue and petechiae. Bone marrow cellularity was low or extremely low in all patients. The karyotype was normal in all patients except patient 2, who was 45,XX,-7. This study was approved by the Institutional Review Board of the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, and written informed consent was obtained from all participants in accordance with the Declaration of Helsinki.
Genomic DNA extraction
Bone marrow cells were collected from patients, and oral epithelial cells were colepithelial cells were collected for normal tissue comparison. Total DNA from bone marrow and oral epithelium was extracted using an EasyPure Genomic DNA Extraction kit (Beijing Tiangen Biotech Co., China). Extracted DNA was resuspended in Tris-EDTA buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.5) and stored at 4°C prior to use.
mtDNA sequencing and data analysis
For the direct sequencing of the entire mtDNA genome, we used 8 primer pairs based on a modification of a published protocol to obtain 8 partially overlapping segments. The amplified mtDNA PCR products were directly sequenced using the BigDye Terminator v3.1 ready reaction kit (Applied Biosystems) and the ABI Prism 3100 Genetic Analyzer (Applied Biosystems). Sequencing primers used for each mtDNA product are shown in Table 2 , and the electropherogram of 8 fragments is shown in Figure 1 .
Experimentally obtained mtDNA sequences were compared with the revised Cambridge Reference Sequence (rCRS) (http://www.mitomap.org/mitomap/mitoseq.html; Andrews et al., 1999) by using the Blast2 program (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi?PAGE_ TYPE=BlastSearch&PROG_DEF=blastn&BLAST_PROG_DEF=megaBlast&SHOW_ DEFAULTS=on&BLAST_SPEC=blast2seq&LINK_LOC=align2seq) and the database search tool MitoAnalyzer (http://www.cstl.nist.gov/biotech/strbase/mitoanalyzer.html, 2001; Lee and Levin, 2002) to determine which polymorphisms and mutations differed from the rCRS and whether the differences caused amino acid changes in the resultant polypeptides. Nucleotide changes that were present in both the bone marrow and oral epithelial cells in the same patient were counted as polymorphisms or homoplasmic mutations, and those that had not already been included in the databases (MITOMAP, mtDB, or GenBank) were considered new polymorphisms. Changes that were only present in bone marrow were counted as mutations or heteroplasmic mutations.
RESULTS
Heteroplasmic mutations of mtDNA
We detected mutations in all 15 specimens, and overall, we detected 61 mutations in Table 1 . mtDNA mutation heteroplasmy detected in patients with aplastic anemia.
Continued on next page X. Cui et al. F = female; M = male; A = adenine; G = guanine; C = cytosine; T = thymine; Ins = insertion; Del = deletion; ND 1-2 and 4-6 = NADH dehydrogenase; RNR 1 and 2 = ribosomal RNA; CYTB = cytochrome b; TRNG = tRNA glycine; TRNE = tRNA glutamic acid; COX1 = cytochrome c oxidase; Ala = alanine; Arg = arginine; Asn = asparagine; Gln = glutamine; Glu = glutamic acid; Gly = glycine; His = histidine; Leu = leucine; Ile = isoleucine; Lys = lysine; Met = methionine; Pro = proline; Ser = serine; Thr = threonine; Trp = tryptophan; Tyr = tyrosine; Val = valine; SC = stop codon. 11 genes, including ND1 (5/8.20%), ND2 (21/34.43%), ND4 (13/21.31%), ND5 (6/9.84%), ND6 (6/9.84%), TRNE (1/1.64%), RNR1 (2/3.28%), RNR2 (1/1.64%), COX1 (1/1.64%), CYTB (4/6.56%), and TRNG (1/1.64%). We also found that there were 16 silent mutations (16/26.23%) and 13 frameshift mutations (13/21.31%) among all mutations. This information is given in Table 1, Table 3 , and Figure 1 . Table 3 . Distribution and number of mtDNA mutations in bone marrow specimens from patients with aplastic anemia.
For abbreviations, see legend to Table 1 .
Mitochondrial sequencing indicated that these mutations were found in the coding region closely related to the mitochondrial oxidative respiratory chain, covering ND1-2 and 4-6, CYTB, and other related genes, and that mutation levels were particularly high in ND2 and ND4. We speculate that this may be an important reason behind the failure of hematopoietic stem cells.
mtDNA polymorphisms in AA patients
In this study, we detected 162 polymorphisms in 15 genomes, including the D-loop region (88/54.32%), RNR1 (18/11.11%), RNR2 (8/4.94%), ND1 (2/1.23%), ND2 (7/4.32%), COX1 (8/4.94%), COX2 (1/0.62%), COX3 (1/0.62%), ATP6 (2/1.23%), ND3 (2/1.23%), ND4L (2/1.23%), ND4 (4/2.47%), ND5 (8/4.94%), ND6 (1/0.62%), and CYTB (10/6.17%) (Table 4) . Interestingly, the majority of these polymorphisms were in the D-loop region, where numerous mutations involved in leukemia and myelodysplastic syndromes are found. However, in this study, no new polymorphisms were found. bone marrow biopsy of patient 1; C. G3834A mutation (arrow) was found in patient 1; D. G13928C mutation was found in patient 3; E. T4248C mutation was found in patient 6; F. A12038T mutation was found in patient 15; Query = revised Cambridge Reference Sequence; Subject = sequence of patients.
DISCUSSION
Acquired mtDNA deletions in the hematopoietic compartment have also been observed to occur in association with severe pancytopenia and reticulocytopenia (Clayton, 1984) . In this study, we detected 61 mutations in 11 genes, including ND1 (5/8.20%), ND2 (21/34.43%), ND4 (13/21.31%), ND5 (6/9.84%), ND6 (6/9.84%), TRNE (1/1.64%), RNR1 (2/3.28%), RNR2 (1/1.64%), COX1 (1/1.64%), CYTB (4/6.56%), and TRNG (1/1.64%). Also, the mutation rate was particularly high in ND2 (15/33.33%) and ND4 (10/22.22%) in patients' mtDNA genome, excepting these silent mutations. These genes are closely linked to oxidation in the respiratory chain. Interestingly, there were no D-loop mutations in these heteroplasmic mutations.
ND1-2 and 4-6, and CYTB are important components of NADH-ubiquinone oxidoreare important components of NADH-ubiquinone oxidoreductase (Complex I) and ubiquinone cytochrome c oxidoreductase (Complex III). Mitochondrial injury is reflected by mtDNA damage as well as by a decline in the levels of mtRNA transcripts, protein synthesis, and mitochondrial function. A decrease in these complex activities can result in a decrease in cellular energy, disruption of cell signaling, and interference with cellular differentiation and apoptosis. Furthermore, deficient mitochondrial ATP production due to mtDNA mutation may promote chromosomal instability (Gattermann, 2004) . Cells with an inadequate ATP supply may have difficulty in correctly segregating their chromosomes during mitosis. These factors may result in a decrease in energy metabolism, which will affect self-renewal and differentiation of the hematopoietic stem cell.
Interestingly, the genes affected were involved in oxidative phosphorylation. In con-. In conIn conIn conn contrast to the mutations involved in hematologic malignancies such as acute myeloblastic leukemia and myelodysplastic syndromes, these mutations were mainly in the D-loop. In these studies, a great deal of nucleotide alterations were detected in the D-loop region in acute myeloblastic leukemia and myelodysplastic syndrome patients, suggesting that the D-loop is a mutational hotspot in human cancer. It was found that leukemia cells utilize glycolysis more vigorously than oxidative phosphorylation in mitochondria (Gattermann, 2000; Shin et al., 2003; Grist et al., 2004; Suganuma et al., 2010) . This may be caused by differences between benign and malignant hematologic disorders. In summary, the mutations occurred in the region that influences the replication and transcription of mtDNA and thus are likely to have impact on function, increasing the permeability of the mitochondrial inner membrane and destroying the membrane potential, which would then trigger caspase activity and eventually cause cell apoptosis. Therefore, the functional defect caused by mtDNA mutations may be the primary cause of bone marrow failure in AA.
